Cargando…

Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease

Safety and efficacy were assessed of different S(+)-ketamine doses combined with propofol administered as anesthesia to common pediatric congenital heart disease (CHD) patients undergoing cardiac interventional surgery to provide reference data as guidance for use in clinical settings. METHODS: Sixt...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenjun, Xu, Fei, Guo, Liyong, Li, Hong, Zhao, Liyun, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646580/
https://www.ncbi.nlm.nih.gov/pubmed/36343069
http://dx.doi.org/10.1097/MD.0000000000031624
_version_ 1784827198626070528
author Liu, Wenjun
Xu, Fei
Guo, Liyong
Li, Hong
Zhao, Liyun
Ma, Jun
author_facet Liu, Wenjun
Xu, Fei
Guo, Liyong
Li, Hong
Zhao, Liyun
Ma, Jun
author_sort Liu, Wenjun
collection PubMed
description Safety and efficacy were assessed of different S(+)-ketamine doses combined with propofol administered as anesthesia to common pediatric congenital heart disease (CHD) patients undergoing cardiac interventional surgery to provide reference data as guidance for use in clinical settings. METHODS: Sixty CHD children admitted to Beijing Anzhen Hospital, Capital Medical University from December 2020 to December 2021 who underwent elective cardiac intervention were assigned to 3 groups (H, L, M, 20 patients/group) using a random number table-based method. Patients received 1% propofol (2 mg/kg) and intravenous injections of S(+)-ketamine (Group L, 0.4 mg/kg; Group M, 0.5 mg/kg; Group H, 0.6 mg/kg) followed by intravenous pumping of 1% propofol (4–6 mg/kg/h). Heart rate (HR), mean arterial pressure, and pulse oxygen saturation were recorded preoperatively (T0), at the time of anesthesia maintenance (T1), at the time of arteriovenous puncture (T2), and when they awakened (T3). Additionally, propofol dose and incidence rates of intraoperative body movement, postoperative agitation, and postoperative nausea/vomiting were recorded. RESULTS: For the 3 groups, Group H awakening time was significantly longer than that of Group L (P = .039). Notably, intergroup intraoperative propofol times differed significantly (P = .009). Meanwhile, T0 to T3 intragroup HR values differences were significant (P = .017; P = .001; P = .005, respectively). Group L HR was significantly elevated at T2 relative to T0 (P = .003), Group M HR was significantly elevated at T1 and T2 relative to T0 (P = .019; P = .003, respectively), and Group H HR values were significantly elevated at T1 and T2 relative to T0 (P = .012; P = .005, respectively). At all 4 time points no statistically significant intergroup differences in mean arterial pressure values were observed (P = .587). T1 to T3 pulse oxygen saturation values for all 3 groups were significantly greater than corresponding T0 values. Although intergroup intraoperative body movement incidence differed significantly (P = .044), intergroup differences in awakening time agitation and postoperative nausea/vomiting incidence rates were insignificant (P = .732, P = .887, respectively). CONCLUSION: Use of 0.6 mg/kg S(+)-ketamine with propofol was most effective as anesthesia for common pediatric CHD patients undergoing cardiac interventional surgery.
format Online
Article
Text
id pubmed-9646580
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96465802022-11-14 Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease Liu, Wenjun Xu, Fei Guo, Liyong Li, Hong Zhao, Liyun Ma, Jun Medicine (Baltimore) 3300 Safety and efficacy were assessed of different S(+)-ketamine doses combined with propofol administered as anesthesia to common pediatric congenital heart disease (CHD) patients undergoing cardiac interventional surgery to provide reference data as guidance for use in clinical settings. METHODS: Sixty CHD children admitted to Beijing Anzhen Hospital, Capital Medical University from December 2020 to December 2021 who underwent elective cardiac intervention were assigned to 3 groups (H, L, M, 20 patients/group) using a random number table-based method. Patients received 1% propofol (2 mg/kg) and intravenous injections of S(+)-ketamine (Group L, 0.4 mg/kg; Group M, 0.5 mg/kg; Group H, 0.6 mg/kg) followed by intravenous pumping of 1% propofol (4–6 mg/kg/h). Heart rate (HR), mean arterial pressure, and pulse oxygen saturation were recorded preoperatively (T0), at the time of anesthesia maintenance (T1), at the time of arteriovenous puncture (T2), and when they awakened (T3). Additionally, propofol dose and incidence rates of intraoperative body movement, postoperative agitation, and postoperative nausea/vomiting were recorded. RESULTS: For the 3 groups, Group H awakening time was significantly longer than that of Group L (P = .039). Notably, intergroup intraoperative propofol times differed significantly (P = .009). Meanwhile, T0 to T3 intragroup HR values differences were significant (P = .017; P = .001; P = .005, respectively). Group L HR was significantly elevated at T2 relative to T0 (P = .003), Group M HR was significantly elevated at T1 and T2 relative to T0 (P = .019; P = .003, respectively), and Group H HR values were significantly elevated at T1 and T2 relative to T0 (P = .012; P = .005, respectively). At all 4 time points no statistically significant intergroup differences in mean arterial pressure values were observed (P = .587). T1 to T3 pulse oxygen saturation values for all 3 groups were significantly greater than corresponding T0 values. Although intergroup intraoperative body movement incidence differed significantly (P = .044), intergroup differences in awakening time agitation and postoperative nausea/vomiting incidence rates were insignificant (P = .732, P = .887, respectively). CONCLUSION: Use of 0.6 mg/kg S(+)-ketamine with propofol was most effective as anesthesia for common pediatric CHD patients undergoing cardiac interventional surgery. Lippincott Williams & Wilkins 2022-11-04 /pmc/articles/PMC9646580/ /pubmed/36343069 http://dx.doi.org/10.1097/MD.0000000000031624 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3300
Liu, Wenjun
Xu, Fei
Guo, Liyong
Li, Hong
Zhao, Liyun
Ma, Jun
Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease
title Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease
title_full Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease
title_fullStr Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease
title_full_unstemmed Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease
title_short Anaesthesia administered as S(+)-ketamine for cardiac intervention in children with common congenital heart disease
title_sort anaesthesia administered as s(+)-ketamine for cardiac intervention in children with common congenital heart disease
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646580/
https://www.ncbi.nlm.nih.gov/pubmed/36343069
http://dx.doi.org/10.1097/MD.0000000000031624
work_keys_str_mv AT liuwenjun anaesthesiaadministeredassketamineforcardiacinterventioninchildrenwithcommoncongenitalheartdisease
AT xufei anaesthesiaadministeredassketamineforcardiacinterventioninchildrenwithcommoncongenitalheartdisease
AT guoliyong anaesthesiaadministeredassketamineforcardiacinterventioninchildrenwithcommoncongenitalheartdisease
AT lihong anaesthesiaadministeredassketamineforcardiacinterventioninchildrenwithcommoncongenitalheartdisease
AT zhaoliyun anaesthesiaadministeredassketamineforcardiacinterventioninchildrenwithcommoncongenitalheartdisease
AT majun anaesthesiaadministeredassketamineforcardiacinterventioninchildrenwithcommoncongenitalheartdisease